Evidence map›Paper›PMID 35451651›Full record

ArticleCellular and molecular life sciences : CMLS2022

Hotair promotes the migration and proliferation in ovarian cancer by miR-222-3p/CDK19 axis.

Lili Fan, Han Lei, Ying Lin, Zhengwei Zhou, Juanni Li, Anqi Wu, Guang Shu, Sébastien Roger, Gang Yin

Open access · hybridAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. International journal of biological sciences · 2026
    Article
  8. AlphaFold for Docking Screens.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Lili Fan *Department of Pathology, School of Basic Medical Sciences, Xiangya HospitalCentral South UniversityHunan Province, Changsha, 410000, China.
Han Lei *Department of Pathology, School of Basic Medical Sciences, Xiangya HospitalCentral South UniversityHunan Province, Changsha, 410000, China.
Ying LinDepartment of Pathology, School of Basic Medical Sciences, Xiangya HospitalCentral South UniversityHunan Province, Changsha, 410000, China.
Zhengwei ZhouDepartment of Pathology, School of Basic Medical Sciences, Xiangya HospitalCentral South UniversityHunan Province, Changsha, 410000, China.
Juanni LiDepartment of Pathology, School of Basic Medical Sciences, Xiangya HospitalCentral South UniversityHunan Province, Changsha, 410000, China.
Anqi WuDepartment of Pathology, School of Basic Medical Sciences, Xiangya HospitalCentral South UniversityHunan Province, Changsha, 410000, China.
Guang ShuDepartment of Pathology, School of Basic Medical Sciences, Xiangya HospitalCentral South UniversityHunan Province, Changsha, 410000, China.
Sébastien RogerEA4245 Transplantation, Immunologie, Inflammation, University of Tours, 37032, Tours, France.
Gang YinDepartment of Pathology, School of Basic Medical Sciences, Xiangya HospitalCentral South UniversityHunan Province, Changsha, 410000, China. gangyin@csu.edu.cn.ORCID http://orcid.org/0000-0003-3753-0753
Central South University · CNGuangzhou University of Chinese Medicine · CNUniversité de Tours · FR

Funding

Fundamental Research Funds for Central Universities of the Central South University No. 502221804National Key Research and Development Program of China Stem Cell and Translational Research No. 2016YFA0102000National Natural Science Foundation of China No. 81572900
6 · The paper itself

Abstract

Previous studies in our laboratory have reported that miR-222-3p was a tumor-suppressive miRNA in OC. This study aims to further understand the regulatory role of miR-222-3p in OC and provide a new mechanism for its prevention and treatment. We first found that miR-222-3p inhibited the migration and proliferation of OC cells. Then, we observed CDK19 was highly expressed in OC and inversely correlated with miR-222-3p. Besides, we observed that miR-222-3p directly binds to the 3'-UTR of CDK19 and inhibits CDK19 translation, thus inhibiting OC cell migration and proliferation in vitro and repressed tumor growth in vivo. We also observed the inhibitory effect of Hotair on miR-222-3p in OC. In addition, Hotair could promote the proliferation and migration of OC cells in vitro and facilitate the growth and metastasis of tumors in vivo. Moreover, Hotair was positively correlated with CDK19 expression. These results suggest Hotair indirectly up-regulates CDK19 through sponging miR-222-3p, which enhances the malignant behavior of OC. This provides a further understanding of the mechanism of the occurrence and development of OC.

Indexed as

Cyclin-Dependent KinasesMicroRNAsOvarian NeoplasmsRNA, Long Noncoding3' Untranslated RegionsCell Line, TumorCell ProliferationFemaleHumans3' Untranslated RegionsCDK19 protein, humanCyclin-Dependent KinasesHOTAIR long untranslated RNA, humanMicroRNAsMIR222, humanRNA, Long NoncodingHotair/miR-222-3p/CDK19 axisMigrationOvarian cancerProliferation

Identifiers

PMID35451651
PMCPMC9033702
OpenAlexW4224271556

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.